{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:21:12Z","timestamp":1776475272911,"version":"3.51.2"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1013117","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000}}],"reference-count":94,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson & Johnson","doi-asserted-by":"crossref","award":["WiSTEM^2D Scholar Award"],"award-info":[{"award-number":["WiSTEM^2D Scholar Award"]}],"id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["T32AI118690"],"award-info":[{"award-number":["T32AI118690"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The success of chimeric antigen receptor (CAR) T-cell therapy in treating hematologic malignancies has generated widespread interest in translating this technology to solid cancers. However, issues like tumor infiltration, the immunosuppressive tumor microenvironment, and tumor heterogeneity limit its efficacy in the solid tumor setting. Recent experimental and clinical studies propose local administration directly into the tumor or at the tumor site to increase CAR T-cell infiltration and improve treatment outcomes. Characteristics of the types of solid tumors that may be the most receptive to this treatment approach remain unclear. In this work, we develop a simplified spatiotemporal model for CAR T-cell treatment of solid tumors, and use numerical simulations to compare the effect of introducing CAR T cells via intratumoral injection versus intracavitary administration in diverse cancer types. We demonstrate that the model can reproduce tumor and CAR T-cell data from small imaging studies of local administration of CAR T cells in mouse models. Our results suggest that locally administered CAR T cells will be most successful against slowly proliferating, highly diffusive tumors. In our simulations, assuming equal detectable tumor diameters at the time of treatment, low average tumor cell density is a better predictor of treatment success than total tumor burden or volume doubling time. These findings affirm the clinical observation that CAR T cells will not perform equally across different types of solid tumors, and suggest that measuring tumor density may be helpful when considering the feasibility of CAR T-cell therapy and planning dosages for a particular patient. We additionally find that local delivery of CAR T cells can result in deep tumor responses, provided that the initial CAR T-cell dose does not contain a significant fraction of exhausted cells.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1013117","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:11:48Z","timestamp":1748967108000},"page":"e1013117","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Spatiotemporal dynamics of tumor\u2013CAR T-cell interaction following local administration in solid cancers"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5695-0203","authenticated-orcid":true,"given":"Katherine","family":"Owens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-825X","authenticated-orcid":true,"given":"Ivana","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"6","key":"pcbi.1013117.ref001","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","article-title":"Long-term outcomes following CAR T cell therapy: what we know so far","volume":"20","author":"KM Cappell","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"pcbi.1013117.ref002","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1158\/1078-0432.CCR-19-1835","article-title":"Enhancing chimeric antigen receptor T-cell efficacy in solid tumors","volume":"26","author":"G Fuc\u00e0","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pcbi.1013117.ref003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","article-title":"CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn","volume":"21","author":"SM Albelda","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"591","key":"pcbi.1013117.ref004","article-title":"SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma","volume":"13","author":"JH Choe","year":"2021","journal-title":"Sci Transl Med"},{"issue":"6537","key":"pcbi.1013117.ref005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"EW Weber","year":"2021","journal-title":"Science"},{"issue":"11","key":"pcbi.1013117.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41587-023-02060-8","article-title":"IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases","volume":"42","author":"Y Zhao","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"12","key":"pcbi.1013117.ref007","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-17-1365","article-title":"T-cell homing therapy for reducing regulatory T cells and preserving effector T-cell function in large solid tumors","volume":"24","author":"J Hu","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"pcbi.1013117.ref008","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"L Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"issue":"5","key":"pcbi.1013117.ref009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41591-020-0827-2","article-title":"Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma","volume":"26","author":"LK Donovan","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"pcbi.1013117.ref010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","article-title":"Regional delivery of chimeric antigen receptor-engineered T cells effectively targets HER2+ breast cancer metastasis to the brain","volume":"24","author":"SJ Priceman","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"11","key":"pcbi.1013117.ref011","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/neuonc\/noz117","article-title":"Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma","volume":"21","author":"J Cui","year":"2019","journal-title":"Neuro Oncol"},{"key":"pcbi.1013117.ref012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jss.2021.11.001","article-title":"Antigen receptor T cells (CAR-T) effectively control tumor growth in a colorectal liver metastasis model","volume":"272","author":"LF Chai","year":"2022","journal-title":"J Surg Res"},{"issue":"3","key":"pcbi.1013117.ref013","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1078-0432.CCR-23-1735","article-title":"Intratumoral delivery of chimeric antigen receptor T cells targeting CD133 effectively treats brain metastases","volume":"30","author":"AM Kieliszek","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"18","key":"pcbi.1013117.ref014","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-15-0428","article-title":"Bioactivity and safety of IL13R\u03b12-redirected chimeric antigen receptor CD8+ T cells in patients with recurrent glioblastoma","volume":"21","author":"CE Brown","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"11","key":"pcbi.1013117.ref015","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/2159-8290.CD-21-0407","article-title":"A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab","volume":"11","author":"PS Adusumilli","year":"2021","journal-title":"Cancer Discov"},{"issue":"6","key":"pcbi.1013117.ref016","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1137","article-title":"Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma","volume":"9","author":"X Tang","year":"2020","journal-title":"Clin Transl Immunol"},{"issue":"9","key":"pcbi.1013117.ref017","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41591-021-01404-8","article-title":"Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis","volume":"27","author":"NA Vitanza","year":"2021","journal-title":"Nat Med"},{"issue":"14","key":"pcbi.1013117.ref018","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1158\/1078-0432.CCR-14-1421","article-title":"Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified T-cell therapy for CEA+ liver metastases","volume":"21","author":"SC Katz","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"11","key":"pcbi.1013117.ref019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cgt.2014.50","article-title":"Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases","volume":"21","author":"A Saied","year":"2014","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"pcbi.1013117.ref020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"CE Brown","year":"2024","journal-title":"Nat Med"},{"issue":"26","key":"pcbi.1013117.ref021","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"CE Brown","year":"2016","journal-title":"N Engl J Med"},{"key":"pcbi.1013117.ref022","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669071","article-title":"Case report: prolonged survival following EGFRvIII CAR T cell treatment for recurrent glioblastoma","volume":"11","author":"JS Durgin","year":"2021","journal-title":"Front Oncol"},{"key":"pcbi.1013117.ref023","article-title":"Case report: combined intravenous infusion and local injection of CAR-T cells induced remission in a relapsed diffuse large B-cell lymphoma patient","volume":"12","author":"L Hu","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"pcbi.1013117.ref024","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/mt.2014.28","article-title":"Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells","volume":"22","author":"A Globerson-Levin","year":"2014","journal-title":"Mol Ther"},{"issue":"1","key":"pcbi.1013117.ref025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40425-018-0340-z","article-title":"Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells","volume":"6","author":"A Nellan","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"261","key":"pcbi.1013117.ref026","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010162","article-title":"Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity","volume":"6","author":"PS Adusumilli","year":"2014","journal-title":"Sci Transl Med"},{"key":"pcbi.1013117.ref027","doi-asserted-by":"crossref","first-page":"106329","DOI":"10.1016\/j.phrs.2022.106329","article-title":"Locoregional delivery of CAR-T cells in the clinic","volume":"182","author":"SM Sagnella","year":"2022","journal-title":"Pharmacol Res"},{"key":"pcbi.1013117.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz253.052","article-title":"A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells","volume":"30","author":"A Curioni","year":"2019","journal-title":"Ann Oncol"},{"key":"pcbi.1013117.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2022.01.003","article-title":"Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I\/II clinical trial","volume":"165","author":"M Ghosn","year":"2022","journal-title":"Lung Cancer"},{"issue":"9","key":"pcbi.1013117.ref030","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/14712598.2020.1786531","article-title":"PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer","volume":"20","author":"D Larcombe-Young","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"12","key":"pcbi.1013117.ref031","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/2326-6066.CIR-17-0189","article-title":"Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer","volume":"5","author":"J Tchou","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"pcbi.1013117.ref032","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cpt.2040","article-title":"Model-based cellular kinetic analysis of chimeric antigen receptor-T cells in humans","volume":"109","author":"C Liu","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"22","key":"pcbi.1013117.ref033","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.3390\/cancers14225576","article-title":"Modeling patient-specific CAR-T cell dynamics: multiphasic kinetics via phenotypic differentiation","volume":"14","author":"EA Paix\u00e3o","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"162","key":"pcbi.1013117.ref034","doi-asserted-by":"crossref","first-page":"20190734","DOI":"10.1098\/rsif.2019.0734","article-title":"Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data","volume":"17","author":"P Sahoo","year":"2020","journal-title":"J R Soc Interface"},{"issue":"4","key":"pcbi.1013117.ref035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cancers13040703","article-title":"Dual-target CAR-Ts with on- and off-tumour activity may override immune suppression in solid cancers: a mathematical proof of concept","volume":"13","author":"O Le\u00f3n-Triana","year":"2021","journal-title":"Cancers (Basel)"},{"key":"pcbi.1013117.ref036","doi-asserted-by":"crossref","DOI":"10.3389\/fsysb.2022.923085","article-title":"A mathematical model for on-target off-tumor effect of CAR-T cells on hliomas","volume":"2","author":"DS Santurio","year":"2022","journal-title":"Front Syst Biol"},{"key":"pcbi.1013117.ref037","doi-asserted-by":"crossref","first-page":"100022","DOI":"10.1016\/j.immuno.2023.100022","article-title":"Modeling interaction of glioma cells and CAR T-cells considering multiple CAR T-cells bindings","volume":"9","author":"R Li","year":"2023","journal-title":"Immunoinformatics (Amst)"},{"key":"pcbi.1013117.ref038","doi-asserted-by":"crossref","first-page":"1115536","DOI":"10.3389\/fimmu.2023.1115536","article-title":"Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables","volume":"14","author":"AB Brummer","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"pcbi.1013117.ref039","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41540-024-00435-4","article-title":"Mathematical modeling insights into improving CAR T cell therapy for solid tumors with bystander effects","volume":"10","author":"E Kara","year":"2024","journal-title":"NPJ Syst Biol Appl"},{"issue":"1947","key":"pcbi.1013117.ref040","first-page":"20210229","article-title":"The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy","volume":"288","author":"GJ Kimmel","year":"2021","journal-title":"Proc Biol Sci"},{"key":"pcbi.1013117.ref041","doi-asserted-by":"crossref","first-page":"105570","DOI":"10.1016\/j.cnsns.2020.105570","article-title":"CAR T cell therapy in B-cell acute lymphoblastic leukaemia: insights from mathematical models","volume":"94","author":"O Le\u00f3n-Triana","year":"2021","journal-title":"Commun Nonlinear Sci Numer Simul"},{"issue":"12","key":"pcbi.1013117.ref042","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms22126371","article-title":"A mathematical description of the bone marrow dynamics during CAR T-cell therapy in B-cell childhood acute lymphoblastic leukemia","volume":"22","author":"\u00c1 Mart\u00ednez-Rubio","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pcbi.1013117.ref043","doi-asserted-by":"crossref","first-page":"109141","DOI":"10.1016\/j.mbs.2024.109141","article-title":"A stochastic framework for evaluating CAR T cell therapy efficacy and variability","volume":"368","author":"C Hoang","year":"2024","journal-title":"Math Biosci"},{"issue":"4","key":"pcbi.1013117.ref044","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/g11040053","article-title":"Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model","volume":"11","author":"E Khailov","year":"2020","journal-title":"Games"},{"issue":"5","key":"pcbi.1013117.ref045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11538-021-00869-5","article-title":"Modeling CAR T-cell therapy with patient preconditioning","volume":"83","author":"K Owens","year":"2021","journal-title":"Bull Math Biol"},{"issue":"12","key":"pcbi.1013117.ref046","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3390\/cancers13122941","article-title":"CARTmath\u2014a mathematical model of CAR-T immunotherapy in preclinical studies of hematological cancers","volume":"13","author":"LRC Barros","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"5","key":"pcbi.1013117.ref047","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.3934\/mbe.2022205","article-title":"A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept","volume":"19","author":"KJ Mahasa","year":"2022","journal-title":"Math Biosci Eng"},{"issue":"6","key":"pcbi.1013117.ref048","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11538-022-01015-5","article-title":"Mathematical modeling of tumor and cancer stem cells treated with CAR-T therapy and inhibition of TGF-\u03b2","volume":"84","author":"ER Swanson","year":"2022","journal-title":"Bull Math Biol"},{"issue":"11","key":"pcbi.1013117.ref049","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1158\/2767-9764.CRC-22-0176","article-title":"Mechanistic modeling of the interplay between host immune system, IL-7 and UCART19 allogeneic CAR-T cells in adult B-cell acute lymphoblastic leukemia","volume":"2","author":"T Derippe","year":"2022","journal-title":"Cancer Res Commun"},{"issue":"3","key":"pcbi.1013117.ref050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1208\/s12248-021-00579-9","article-title":"A systematic review of the efforts and hindrances of modeling and simulation of CAR T-cell therapy","volume":"23","author":"U Nukala","year":"2021","journal-title":"AAPS J"},{"key":"pcbi.1013117.ref051","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semcancer.2023.05.009","article-title":"A systems and computational biology perspective on advancing CAR therapy","volume":"94","author":"V Tserunyan","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"pcbi.1013117.ref052","volume-title":"Mathematical biology II: spatial models and biomedical applications","author":"JD Murray","year":"2001"},{"issue":"1","key":"pcbi.1013117.ref053","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2184.1995.tb00036.x","article-title":"A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth","volume":"28","author":"P Tracqui","year":"1995","journal-title":"Cell Prolif"},{"issue":"6","key":"pcbi.1013117.ref054","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00005072-199706000-00008","article-title":"The interaction of growth rates and diffusion coefficients in a three-dimensional mathematical model of gliomas","volume":"56","author":"PK Burgess","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"pcbi.1013117.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2003.06.001","article-title":"Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion","volume":"216","author":"KR Swanson","year":"2003","journal-title":"J Neurol Sci"},{"issue":"1","key":"pcbi.1013117.ref056","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bjc.6604125","article-title":"A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle","volume":"98","author":"KR Swanson","year":"2008","journal-title":"Br J Cancer"},{"key":"pcbi.1013117.ref057","doi-asserted-by":"crossref","first-page":"021907","DOI":"10.1103\/PhysRevE.65.021907","article-title":"Reaction-diffusion model for the growth of avascular tumor","volume":"65","author":"Jr Ferreira SC","year":"2002","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"issue":"3","key":"pcbi.1013117.ref058","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-05-3166","article-title":"An integrated computational\/experimental model of tumor invasion","volume":"66","author":"HB Frieboes","year":"2006","journal-title":"Cancer Res"},{"issue":"24","key":"pcbi.1013117.ref059","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1158\/0008-5472.CAN-11-1399","article-title":"Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology","volume":"71","author":"KR Swanson","year":"2011","journal-title":"Cancer Res"},{"issue":"12","key":"pcbi.1013117.ref060","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1007\/s11538-012-9786-1","article-title":"Hypoxic cell waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications","volume":"74","author":"A Mart\u00ednez-Gonz\u00e1lez","year":"2012","journal-title":"Bull Math Biol"},{"issue":"1","key":"pcbi.1013117.ref061","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1529\/biophysj.106.093468","article-title":"A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment","volume":"92","author":"AM Stein","year":"2007","journal-title":"Biophys J"},{"issue":"1","key":"pcbi.1013117.ref062","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1109\/TMI.2009.2026413","article-title":"Image guided personalization of reaction-diffusion type tumor growth models using modified anisotropic eikonal equations","volume":"29","author":"E Konukoglu","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"6","key":"pcbi.1013117.ref063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002556","article-title":"The impact of phenotypic switching on glioblastoma growth and invasion","volume":"8","author":"P Gerlee","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1013117.ref064","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jtbi.2013.01.014","article-title":"Mathematical modelling of glioma growth: the use of diffusion tensor imaging (DTI) data to predict the anisotropic pathways of cancer invasion","volume":"323","author":"KJ Painter","year":"2013","journal-title":"J Theor Biol"},{"issue":"128","key":"pcbi.1013117.ref065","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2016.1010","article-title":"A mechanically coupled reaction\u2013diffusion model that incorporates intra-tumoural heterogeneity to predict in vivo glioma growth","volume":"14","author":"DA Hormuth","year":"2017","journal-title":"J R Soc Interface"},{"issue":"1","key":"pcbi.1013117.ref066","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/imammb\/21.1.1","article-title":"Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour","volume":"21","author":"A Matzavinos","year":"2004","journal-title":"Math Med Biol"},{"issue":"9","key":"pcbi.1013117.ref067","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1073\/pnas.1817652116","article-title":"Infiltration of CD8+ T cells into tumor cell clusters in triple-negative breast cancer","volume":"116","author":"X Li","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pcbi.1013117.ref068","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1063\/1.3699060","article-title":"Integrated intravital microscopy and mathematical modeling to optimize nanotherapeutics delivery to tumors","volume":"2","author":"AL van de Ven","year":"2012","journal-title":"AIP Adv"},{"issue":"12","key":"pcbi.1013117.ref069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144888","article-title":"Computational modeling of tumor response to drug release from vasculature-bound nanoparticles","volume":"10","author":"LT Curtis","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"pcbi.1013117.ref070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/nnm.15.195","article-title":"An interdisciplinary computational\/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity","volume":"11","author":"LT Curtis","year":"2016","journal-title":"Nanomedicine (Lond)"},{"issue":"6","key":"pcbi.1013117.ref071","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.98.062408","article-title":"Modeling of drug diffusion in a solid tumor leading to tumor cell death","volume":"98","author":"A Rahman","year":"2018","journal-title":"Phys Rev E"},{"key":"pcbi.1013117.ref072","doi-asserted-by":"crossref","first-page":"062425","DOI":"10.1103\/PhysRevE.102.062425","article-title":"Tumor ablation due to inhomogeneous anisotropic diffusion in generic three-dimensional topologies","volume":"102","author":"E Kara","year":"2020","journal-title":"Phys Rev E"},{"issue":"12","key":"pcbi.1013117.ref073","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1093\/neuonc\/noad109","article-title":"Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression","volume":"25","author":"M Ratliff","year":"2023","journal-title":"Neuro Oncol"},{"issue":"14","key":"pcbi.1013117.ref074","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.4161\/cc.9.14.12248","article-title":"microRNA-451: a conditional switch controlling glioma cell proliferation and migration","volume":"9","author":"J Godlewski","year":"2010","journal-title":"Cell Cycle"},{"issue":"48","key":"pcbi.1013117.ref075","doi-asserted-by":"crossref","first-page":"24275","DOI":"10.1073\/pnas.1903854116","article-title":"Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice","volume":"116","author":"M Mulazzani","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"pcbi.1013117.ref076","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1158\/0008-5472.CAN-05-0564","article-title":"A validated mathematical model of cell-mediated immune response to tumor growth","volume":"65","author":"LG de Pillis","year":"2005","journal-title":"Cancer Res"},{"issue":"3","key":"pcbi.1013117.ref077","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3171\/jns.1997.86.3.0525","article-title":"Isolation and characterization of human malignant glioma cells from histologically normal brain","volume":"86","author":"DL Silbergeld","year":"1997","journal-title":"J Neurosurg"},{"issue":"22","key":"pcbi.1013117.ref078","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1158\/0008-5472.CAN-14-2945","article-title":"Predicting the response of breast cancer to neoadjuvant therapy using a mechanically coupled reaction-diffusion model","volume":"75","author":"JA Weis","year":"2015","journal-title":"Cancer Res"},{"issue":"73","key":"pcbi.1013117.ref079","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1098\/rsif.2012.0030","article-title":"Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling","volume":"9","author":"SC Massey","year":"2012","journal-title":"J R Soc Interface"},{"issue":"1","key":"pcbi.1013117.ref080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/imammb\/dqr002","article-title":"Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images","volume":"29","author":"S Gu","year":"2012","journal-title":"Math Med Biol"},{"issue":"6","key":"pcbi.1013117.ref081","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0090-3019(83)90029-0","article-title":"Estimation of rate of growth of malignant brain tumors by computed tomography scanning","volume":"20","author":"T Yamashita","year":"1983","journal-title":"Surg Neurol"},{"issue":"9","key":"pcbi.1013117.ref082","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00330-014-3256-0","article-title":"Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound","volume":"24","author":"EB Ryu","year":"2014","journal-title":"Eur Radiol"},{"issue":"2","key":"pcbi.1013117.ref083","first-page":"401","article-title":"Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis","volume":"70","author":"P Nathani","year":"2021","journal-title":"Gut"},{"issue":"2","key":"pcbi.1013117.ref084","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"22","key":"pcbi.1013117.ref085","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1182\/bloodadvances.2020003001","article-title":"Predictive factors of early progression after CAR T-cell therapy in relapsed\/refractory diffuse large B-cell lymphoma","volume":"4","author":"L Vercellino","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"pcbi.1013117.ref086","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-018-0278-6","article-title":"CAR-T cells: the long and winding road to solid tumors","volume":"9","author":"MM D\u2019Aloia","year":"2018","journal-title":"Cell Death Dis"},{"issue":"22","key":"pcbi.1013117.ref087","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1158\/0008-5472.CAN-10-2880","article-title":"Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor","volume":"70","author":"Y Zhao","year":"2010","journal-title":"Cancer Res"},{"key":"pcbi.1013117.ref088","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.omto.2021.06.006","article-title":"Imaging CAR T-cell kinetics in solid tumors: translational implications","volume":"22","author":"MS Skovgard","year":"2021","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"pcbi.1013117.ref089","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"AH Long","year":"2015","journal-title":"Nat Med"},{"issue":"6","key":"pcbi.1013117.ref090","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3892\/ol.2013.1612","article-title":"Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma","volume":"6","author":"Z Weng","year":"2013","journal-title":"Oncol Lett"},{"key":"pcbi.1013117.ref091","doi-asserted-by":"crossref","first-page":"849363","DOI":"10.3389\/fmolb.2022.849363","article-title":"Mapping CAR T-cell design space using agent-based models","volume":"9","author":"AN Prybutok","year":"2022","journal-title":"Front Mol Biosci"},{"issue":"303","key":"pcbi.1013117.ref092","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5415","article-title":"Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia","volume":"7","author":"DL Porter","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"pcbi.1013117.ref093","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S0305004100023197","article-title":"A practical method for numerical evaluation of solutions of partial differential equations of the heat conduction type","volume":"43","author":"J Crank","year":"1947","journal-title":"Proc Camb Phil Soc"},{"key":"pcbi.1013117.ref094","unstructured":"Rohatgi A. Webplotdigitizer: Version 4.6. 2022. Available from: https:\/\/automeris.io\/WebPlotDigitizer"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1013117","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T13:51:18Z","timestamp":1749822678000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013117"}},"subtitle":[],"editor":[{"given":"James R","family":"Faeder","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":94,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1013117","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.08.29.610392","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}